Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Osteoporosis: a paradox in ankylosing spondylitis.

Carter S, Lories RJ.

Curr Osteoporos Rep. 2011 Sep;9(3):112-5. doi: 10.1007/s11914-011-0058-z.

PMID:
21647573
2.

Osteoporosis in inflammatory joint diseases.

Roux C.

Osteoporos Int. 2011 Feb;22(2):421-33. doi: 10.1007/s00198-010-1319-x. Epub 2010 Jun 15. Review.

PMID:
20552328
3.

Can we stop progression of ankylosing spondylitis?

Schett G, Rudwaleit M.

Best Pract Res Clin Rheumatol. 2010 Jun;24(3):363-71. doi: 10.1016/j.berh.2010.01.005.

PMID:
20534370
4.

Bone loss as well as bone formation is a feature of progressive ankylosing spondylitis.

Will R, Palmer R, Bhalla AK, Ring F, Calin A.

Br J Rheumatol. 1990 Dec;29(6):498-9. No abstract available.

PMID:
2099764
5.

Bone formation versus bone resorption in ankylosing spondylitis.

Schett G.

Adv Exp Med Biol. 2009;649:114-21. Review.

PMID:
19731624
6.

[Osteoporosis in ankylosing spondylitis].

Toussirot E, Wendling D.

Presse Med. 1996 Apr 27;25(15):720-4. Review. French.

PMID:
8685137
7.

Osteoporosis and vertebral fractures in ankylosing spondylitis.

Davey-Ranasinghe N, Deodhar A.

Curr Opin Rheumatol. 2013 Jul;25(4):509-16. doi: 10.1097/BOR.0b013e3283620777. Review.

PMID:
23719363
8.

Osteoporosis and ankylosing spondylitis.

El Maghraoui A.

Joint Bone Spine. 2004 Jul;71(4):291-5. Review.

PMID:
15288853
9.

Molecular and cellular biology of new bone formation: insights into the ankylosis of ankylosing spondylitis.

Zhang X, Aubin JE, Inman RD.

Curr Opin Rheumatol. 2003 Jul;15(4):387-93. Review.

PMID:
12819465
10.

Inflammation and destruction of the joints--the Wnt pathway.

Polzer K, Diarra D, Zwerina J, Schett G.

Joint Bone Spine. 2008 Mar;75(2):105-7. doi: 10.1016/j.jbspin.2007.10.005. Epub 2008 Jan 30. Review. No abstract available. Erratum in: Joint Bone Spine. 2008 Jul;75(4):516.

PMID:
18313347
11.

Osteoporosis in ankylosing spondylitis.

Magrey M, Khan MA.

Curr Rheumatol Rep. 2010 Oct;12(5):332-6. doi: 10.1007/s11926-010-0122-1.

PMID:
20680529
12.

Bone loss in ankylosing spondylitis: can we put the puzzle together?

Wendling D.

J Rheumatol. 2005 Jul;32(7):1184-5. Review. No abstract available.

13.

Osteomalacia and osteoporosis in a woman with ankylosing spondylitis.

Kohlmeier LA, Federman M, Leboff MS.

J Bone Miner Res. 1996 May;11(5):697-703.

PMID:
9157786
14.

Osteoporosis in early ankylosing spondylitis: a primary pathological event?

Will R, Palmer R, Bhalla AK, Ring F, Calin A.

Lancet. 1989 Dec 23-30;2(8678-8679):1483-5.

PMID:
2574769
15.

Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis.

Lange U, Teichmann J, Strunk J, Müller-Ladner U, Schmidt KL.

Osteoporos Int. 2005 Dec;16(12):1999-2004. Epub 2005 Sep 20.

PMID:
16172800
16.

Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis.

Martin TJ, Sims NA, Ng KW.

Osteoporos Int. 2008 Aug;19(8):1125-38. doi: 10.1007/s00198-008-0575-5. Epub 2008 Mar 13. Review.

PMID:
18338097
17.

Pathophysiology of new bone formation and ankylosis in spondyloarthritis.

Lories RJ, Schett G.

Rheum Dis Clin North Am. 2012 Aug;38(3):555-67. doi: 10.1016/j.rdc.2012.08.003. Epub 2012 Sep 7. Review.

PMID:
23083755
18.

Osteoporosis, body composition, and bone turnover in ankylosing spondylitis.

El Maghraoui A, Borderie D, Cherruau B, Edouard R, Dougados M, Roux C.

J Rheumatol. 1999 Oct;26(10):2205-9.

PMID:
10529141
19.

[Human parathyroid hormone (1-34) as a new therapeutic agent for osteoporosis].

Isogai Y.

Clin Calcium. 2005 Jan;15(1):18-24. Review. Japanese.

PMID:
15632468
20.

Clinical studies on bone-related outcome and the effect of TNF-α blocking therapy in ankylosing spondylitis.

Arends S, Spoorenberg A, Brouwer E, van der Veer E.

Curr Opin Rheumatol. 2014 May;26(3):259-68. doi: 10.1097/BOR.0000000000000053. Review.

PMID:
24625371

Supplemental Content

Support Center